UniProt ID | TRIPC_HUMAN | |
---|---|---|
UniProt AC | Q14669 | |
Protein Name | E3 ubiquitin-protein ligase TRIP12 | |
Gene Name | TRIP12 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1992 | |
Subcellular Localization | Nucleus, nucleoplasm . | |
Protein Description | E3 ubiquitin-protein ligase involved in ubiquitin fusion degradation (UFD) pathway and regulation of DNA repair. Part of the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination of protein at their N-terminus, regardeless of the presence of lysine residues in target proteins. In normal cells, mediates ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A, a lysine-less tumor suppressor required for p53/TP53 activation under oncogenic stress. In cancer cells, however, isoform p19ARF/ARF and TRIP12 are located in different cell compartments, preventing isoform p19ARF/ARF ubiquitination and degradation. Does not mediate ubiquitination of isoform p16-INK4a of CDKN2A. Also catalyzes ubiquitination of NAE1 and SMARCE1, leading to their degradation. Ubiquitination and degradation of target proteins is regulated by interaction with proteins such as MYC, TRADD or SMARCC1, which disrupt the interaction between TRIP12 and target proteins. Acts as a key regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes.. | |
Protein Sequence | MSNRPNNNPGGSLRRSQRNTAGAQPQDDSIGGRSCSSSSAVIVPQPEDPDRANTSERQKTGQVPKKDNSRGVKRSASPDYNRTNSPSSAKKPKALQHTESPSETNKPHSKSKKRHLDQEQQLKSAQSPSTSKAHTRKSGATGGSRSQKRKRTESSCVKSGSGSESTGAEERSAKPTKLASKSATSAKAGCSTITDSSSAASTSSSSSAVASASSTVPPGARVKQGKDQNKARRSRSASSPSPRRSSREKEQSKTGGSSKFDWAARFSPKVSLPKTKLSLPGSSKSETSKPGPSGLQAKLASLRKSTKKRSESPPAELPSLRRSTRQKTTGSCASTSRRGSGLGKRGAAEARRQEKMADPESNQEAVNSSAARTDEAPQGAAGAVGMTTSGESESDDSEMGRLQALLEARGLPPHLFGPLGPRMSQLFHRTIGSGASSKAQQLLQGLQASDESQQLQAVIEMCQLLVMGNEETLGGFPVKSVVPALITLLQMEHNFDIMNHACRALTYMMEALPRSSAVVVDAIPVFLEKLQVIQCIDVAEQALTALEMLSRRHSKAILQAGGLADCLLYLEFFSINAQRNALAIAANCCQSITPDEFHFVADSLPLLTQRLTHQDKKSVESTCLCFARLVDNFQHEENLLQQVASKDLLTNVQQLLVVTPPILSSGMFIMVVRMFSLMCSNCPTLAVQLMKQNIAETLHFLLCGASNGSCQEQIDLVPRSPQELYELTSLICELMPCLPKEGIFAVDTMLKKGNAQNTDGAIWQWRDDRGLWHPYNRIDSRIIEQINEDTGTARAIQRKPNPLANSNTSGYSESKKDDARAQLMKEDPELAKSFIKTLFGVLYEVYSSSAGPAVRHKCLRAILRIIYFADAELLKDVLKNHAVSSHIASMLSSQDLKIVVGALQMAEILMQKLPDIFSVYFRREGVMHQVKHLAESESLLTSPPKACTNGSGSMGSTTSVSSGTATAATHAAADLGSPSLQHSRDDSLDLSPQGRLSDVLKRKRLPKRGPRRPKYSPPRDDDKVDNQAKSPTTTQSPKSSFLASLNPKTWGRLSTQSNSNNIEPARTAGGSGLARAASKDTISNNREKIKGWIKEQAHKFVERYFSSENMDGSNPALNVLQRLCAATEQLNLQVDGGAECLVEIRSIVSESDVSSFEIQHSGFVKQLLLYLTSKSEKDAVSREIRLKRFLHVFFSSPLPGEEPIGRVEPVGNAPLLALVHKMNNCLSQMEQFPVKVHDFPSGNGTGGSFSLNRGSQALKFFNTHQLKCQLQRHPDCANVKQWKGGPVKIDPLALVQAIERYLVVRGYGRVREDDEDSDDDGSDEEIDESLAAQFLNSGNVRHRLQFYIGEHLLPYNMTVYQAVRQFSIQAEDERESTDDESNPLGRAGIWTKTHTIWYKPVREDEESNKDCVGGKRGRAQTAPTKTSPRNAKKHDELWHDGVCPSVSNPLEVYLIPTPPENITFEDPSLDVILLLRVLHAISRYWYYLYDNAMCKEIIPTSEFINSKLTAKANRQLQDPLVIMTGNIPTWLTELGKTCPFFFPFDTRQMLFYVTAFDRDRAMQRLLDTNPEINQSDSQDSRVAPRLDRKKRTVNREELLKQAESVMQDLGSSRAMLEIQYENEVGTGLGPTLEFYALVSQELQRADLGLWRGEEVTLSNPKGSQEGTKYIQNLQGLFALPFGRTAKPAHIAKVKMKFRFLGKLMAKAIMDFRLVDLPLGLPFYKWMLRQETSLTSHDLFDIDPVVARSVYHLEDIVRQKKRLEQDKSQTKESLQYALETLTMNGCSVEDLGLDFTLPGFPNIELKKGGKDIPVTIHNLEEYLRLVIFWALNEGVSRQFDSFRDGFESVFPLSHLQYFYPEELDQLLCGSKADTWDAKTLMECCRPDHGYTHDSRAVKFLFEILSSFDNEQQRLFLQFVTGSPRLPVGGFRSLNPPLTIVRKTFESTENPDDFLPSVMTCVNYLKLPDYSSIEIMREKLLIAAREGQQSFHLS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSNRPNNNP ------CCCCCCCCC | 53.50 | 21406692 | |
12 | Phosphorylation | PNNNPGGSLRRSQRN CCCCCCCCCCHHHCC | 25.31 | 23401153 | |
34 | Phosphorylation | DDSIGGRSCSSSSAV CCCCCCCCCCCCCCE | 22.94 | 21712546 | |
36 | Phosphorylation | SIGGRSCSSSSAVIV CCCCCCCCCCCCEEE | 34.20 | 24719451 | |
38 | Phosphorylation | GGRSCSSSSAVIVPQ CCCCCCCCCCEEECC | 13.16 | 28555341 | |
44 (in isoform 3) | Phosphorylation | - | 32.65 | 30266825 | |
45 (in isoform 3) | Phosphorylation | - | 43.02 | 30266825 | |
49 (in isoform 3) | Phosphorylation | - | 31.18 | 30266825 | |
52 (in isoform 3) | Phosphorylation | - | 30.91 | - | |
54 | Phosphorylation | EDPDRANTSERQKTG CCCCCCCCCHHHHCC | 30.86 | 28555341 | |
54 (in isoform 3) | Phosphorylation | - | 30.86 | - | |
75 | Phosphorylation | NSRGVKRSASPDYNR CCCCCCCCCCCCCCC | 27.64 | 30266825 | |
77 | Phosphorylation | RGVKRSASPDYNRTN CCCCCCCCCCCCCCC | 21.39 | 29255136 | |
80 | Phosphorylation | KRSASPDYNRTNSPS CCCCCCCCCCCCCCC | 15.21 | 30266825 | |
83 | Phosphorylation | ASPDYNRTNSPSSAK CCCCCCCCCCCCCCC | 36.09 | 25159151 | |
85 | Phosphorylation | PDYNRTNSPSSAKKP CCCCCCCCCCCCCCC | 26.08 | 25159151 | |
87 | Phosphorylation | YNRTNSPSSAKKPKA CCCCCCCCCCCCCCC | 42.63 | 22617229 | |
88 | Phosphorylation | NRTNSPSSAKKPKAL CCCCCCCCCCCCCCC | 47.71 | 21955146 | |
90 (in isoform 4) | Phosphorylation | - | 72.12 | 18669648 | |
98 | Phosphorylation | KPKALQHTESPSETN CCCCCCCCCCCCCCC | 25.79 | 29255136 | |
100 | Phosphorylation | KALQHTESPSETNKP CCCCCCCCCCCCCCC | 34.58 | 23401153 | |
102 | Phosphorylation | LQHTESPSETNKPHS CCCCCCCCCCCCCCC | 67.35 | 30266825 | |
104 | Phosphorylation | HTESPSETNKPHSKS CCCCCCCCCCCCCHH | 53.53 | 29255136 | |
109 | Phosphorylation | SETNKPHSKSKKRHL CCCCCCCCHHHHHHC | 47.34 | 25159151 | |
111 | Phosphorylation | TNKPHSKSKKRHLDQ CCCCCCHHHHHHCCH | 46.56 | 26434776 | |
123 | Methylation | LDQEQQLKSAQSPST CCHHHHHHHCCCCCC | 39.13 | 115979483 | |
127 | Phosphorylation | QQLKSAQSPSTSKAH HHHHHCCCCCCCCHH | 22.12 | 24719451 | |
129 | Phosphorylation | LKSAQSPSTSKAHTR HHHCCCCCCCCHHHH | 51.03 | 28176443 | |
130 | Phosphorylation | KSAQSPSTSKAHTRK HHCCCCCCCCHHHHC | 37.32 | 28985074 | |
148 | Acetylation | TGGSRSQKRKRTESS CCCCHHHHCCCCCCC | 62.22 | 19822159 | |
152 | Phosphorylation | RSQKRKRTESSCVKS HHHHCCCCCCCCCCC | 43.16 | - | |
155 | Phosphorylation | KRKRTESSCVKSGSG HCCCCCCCCCCCCCC | 19.39 | 30576142 | |
159 | Phosphorylation | TESSCVKSGSGSEST CCCCCCCCCCCCCCC | 20.14 | 25850435 | |
161 | Phosphorylation | SSCVKSGSGSESTGA CCCCCCCCCCCCCCC | 46.35 | 29255136 | |
163 | Phosphorylation | CVKSGSGSESTGAEE CCCCCCCCCCCCCCH | 30.03 | 25850435 | |
165 | Phosphorylation | KSGSGSESTGAEERS CCCCCCCCCCCCHHC | 33.56 | 25056879 | |
166 | Phosphorylation | SGSGSESTGAEERSA CCCCCCCCCCCHHCC | 36.04 | 26074081 | |
181 | Acetylation | KPTKLASKSATSAKA CCCCHHCCCCCCCCC | 38.20 | 25953088 | |
192 | Phosphorylation | SAKAGCSTITDSSSA CCCCCCCCCCCCCCC | 31.79 | - | |
194 | Phosphorylation | KAGCSTITDSSSAAS CCCCCCCCCCCCCCC | 29.89 | - | |
214 | Phosphorylation | SAVASASSTVPPGAR CCHHHCCCCCCCCCC | 32.89 | 24260401 | |
223 | Methylation | VPPGARVKQGKDQNK CCCCCCCCCCCCCHH | 48.02 | 116252675 | |
234 | Phosphorylation | DQNKARRSRSASSPS CCHHHHHHHCCCCCC | 25.65 | 23403867 | |
236 | Phosphorylation | NKARRSRSASSPSPR HHHHHHHCCCCCCCC | 33.48 | 28258704 | |
238 | Phosphorylation | ARRSRSASSPSPRRS HHHHHCCCCCCCCCC | 43.99 | 23403867 | |
239 | Phosphorylation | RRSRSASSPSPRRSS HHHHCCCCCCCCCCH | 29.16 | 28176443 | |
241 | Phosphorylation | SRSASSPSPRRSSRE HHCCCCCCCCCCHHH | 32.74 | 28176443 | |
245 | Phosphorylation | SSPSPRRSSREKEQS CCCCCCCCHHHHHHH | 34.72 | 26074081 | |
246 | Phosphorylation | SPSPRRSSREKEQSK CCCCCCCHHHHHHHC | 42.52 | 26074081 | |
259 | Acetylation | SKTGGSSKFDWAARF HCCCCCCCCCHHHHC | 49.38 | 25953088 | |
259 | Ubiquitination | SKTGGSSKFDWAARF HCCCCCCCCCHHHHC | 49.38 | - | |
267 | Phosphorylation | FDWAARFSPKVSLPK CCHHHHCCCCCCCCC | 20.47 | 25159151 | |
271 | Phosphorylation | ARFSPKVSLPKTKLS HHCCCCCCCCCCCCC | 45.11 | 30576142 | |
276 | Acetylation | KVSLPKTKLSLPGSS CCCCCCCCCCCCCCC | 42.05 | 25953088 | |
276 | Ubiquitination | KVSLPKTKLSLPGSS CCCCCCCCCCCCCCC | 42.05 | - | |
278 | Phosphorylation | SLPKTKLSLPGSSKS CCCCCCCCCCCCCCC | 33.79 | 25159151 | |
282 | Phosphorylation | TKLSLPGSSKSETSK CCCCCCCCCCCCCCC | 32.43 | 20068231 | |
283 | Phosphorylation | KLSLPGSSKSETSKP CCCCCCCCCCCCCCC | 46.22 | 20068231 | |
285 | Phosphorylation | SLPGSSKSETSKPGP CCCCCCCCCCCCCCC | 48.32 | 20068230 | |
287 | Phosphorylation | PGSSKSETSKPGPSG CCCCCCCCCCCCCCH | 49.49 | - | |
288 | Phosphorylation | GSSKSETSKPGPSGL CCCCCCCCCCCCCHH | 32.57 | - | |
289 | Ubiquitination | SSKSETSKPGPSGLQ CCCCCCCCCCCCHHH | 62.50 | - | |
293 | Phosphorylation | ETSKPGPSGLQAKLA CCCCCCCCHHHHHHH | 59.04 | 24114839 | |
298 | Acetylation | GPSGLQAKLASLRKS CCCHHHHHHHHHHHH | 31.46 | 25953088 | |
298 | Ubiquitination | GPSGLQAKLASLRKS CCCHHHHHHHHHHHH | 31.46 | 21906983 | |
298 | Ubiquitination | GPSGLQAKLASLRKS CCCHHHHHHHHHHHH | 31.46 | 21890473 | |
301 | Phosphorylation | GLQAKLASLRKSTKK HHHHHHHHHHHHCCC | 38.86 | 24719451 | |
305 | Phosphorylation | KLASLRKSTKKRSES HHHHHHHHCCCCCCC | 38.74 | 26434776 | |
306 | Phosphorylation | LASLRKSTKKRSESP HHHHHHHCCCCCCCC | 43.55 | 26434776 | |
308 | Methylation | SLRKSTKKRSESPPA HHHHHCCCCCCCCCC | 62.33 | 116252683 | |
310 | Phosphorylation | RKSTKKRSESPPAEL HHHCCCCCCCCCCCC | 51.83 | 29255136 | |
312 | Phosphorylation | STKKRSESPPAELPS HCCCCCCCCCCCCCH | 37.11 | 19664994 | |
319 | Phosphorylation | SPPAELPSLRRSTRQ CCCCCCCHHHHCCCC | 47.32 | 30266825 | |
327 | Ubiquitination | LRRSTRQKTTGSCAS HHHCCCCCCCCCCCC | 44.77 | - | |
328 | O-linked_Glycosylation | RRSTRQKTTGSCAST HHCCCCCCCCCCCCC | 28.22 | OGP | |
329 | O-linked_Glycosylation | RSTRQKTTGSCASTS HCCCCCCCCCCCCCC | 33.85 | OGP | |
329 | Phosphorylation | RSTRQKTTGSCASTS HCCCCCCCCCCCCCC | 33.85 | 20068230 | |
331 | O-linked_Glycosylation | TRQKTTGSCASTSRR CCCCCCCCCCCCCCC | 12.38 | OGP | |
331 | Phosphorylation | TRQKTTGSCASTSRR CCCCCCCCCCCCCCC | 12.38 | 20068230 | |
334 | Phosphorylation | KTTGSCASTSRRGSG CCCCCCCCCCCCCCC | 31.10 | 30576142 | |
340 | Phosphorylation | ASTSRRGSGLGKRGA CCCCCCCCCCCHHHH | 29.09 | 30576142 | |
340 | Ubiquitination | ASTSRRGSGLGKRGA CCCCCCCCCCCHHHH | 29.09 | 21890473 | |
355 | Ubiquitination | AEARRQEKMADPESN HHHHHHHHHCCCCHH | 30.93 | 21906983 | |
356 | Sulfoxidation | EARRQEKMADPESNQ HHHHHHHHCCCCHHH | 5.14 | 21406390 | |
361 | Phosphorylation | EKMADPESNQEAVNS HHHCCCCHHHHHHHH | 49.56 | - | |
369 | Phosphorylation | NQEAVNSSAARTDEA HHHHHHHHHCCCCCC | 22.27 | - | |
373 | Phosphorylation | VNSSAARTDEAPQGA HHHHHCCCCCCCCCC | 33.20 | 24043423 | |
387 | Phosphorylation | AAGAVGMTTSGESES CCCCCCCCCCCCCCC | 16.33 | 18669648 | |
388 | Phosphorylation | AGAVGMTTSGESESD CCCCCCCCCCCCCCC | 26.33 | 24043423 | |
389 | Phosphorylation | GAVGMTTSGESESDD CCCCCCCCCCCCCCC | 31.25 | 24043423 | |
392 | Phosphorylation | GMTTSGESESDDSEM CCCCCCCCCCCCCHH | 46.02 | 24043423 | |
393 (in isoform 2) | Phosphorylation | - | 54.61 | 18669648 | |
394 | Phosphorylation | TTSGESESDDSEMGR CCCCCCCCCCCHHHH | 56.87 | 24043423 | |
397 | Phosphorylation | GESESDDSEMGRLQA CCCCCCCCHHHHHHH | 34.18 | 27251789 | |
422 | Methylation | LFGPLGPRMSQLFHR HCCCCCHHHHHHHHH | 35.27 | 54560333 | |
424 | Phosphorylation | GPLGPRMSQLFHRTI CCCCHHHHHHHHHHH | 25.63 | 23401153 | |
435 (in isoform 3) | Phosphorylation | - | 16.60 | 18669648 | |
507 | Phosphorylation | HACRALTYMMEALPR HHHHHHHHHHHHCCC | 8.70 | 17053785 | |
515 | Phosphorylation | MMEALPRSSAVVVDA HHHHCCCCCCCCCCC | 22.25 | 23403867 | |
516 | Phosphorylation | MEALPRSSAVVVDAI HHHCCCCCCCCCCCH | 26.77 | 23403867 | |
617 | Malonylation | RLTHQDKKSVESTCL HCCCCCHHHHHHHHH | 68.94 | 26320211 | |
617 | Ubiquitination | RLTHQDKKSVESTCL HCCCCCHHHHHHHHH | 68.94 | - | |
650 | Phosphorylation | VASKDLLTNVQQLLV HHCHHHHHHHHHHHH | 40.41 | - | |
748 | Phosphorylation | EGIFAVDTMLKKGNA CCEEEHHHHHHCCCC | 20.15 | 25850435 | |
751 | Ubiquitination | FAVDTMLKKGNAQNT EEHHHHHHCCCCCCC | 48.05 | - | |
752 | Ubiquitination | AVDTMLKKGNAQNTD EHHHHHHCCCCCCCC | 54.13 | - | |
758 | Phosphorylation | KKGNAQNTDGAIWQW HCCCCCCCCCCCEEE | 24.59 | 20068231 | |
768 | Ubiquitination | AIWQWRDDRGLWHPY CCEEEECCCCCCCCC | 37.66 | 21890473 | |
768 | Ubiquitination | AIWQWRDDRGLWHPY CCEEEECCCCCCCCC | 37.66 | 21890473 | |
778 | Ubiquitination | LWHPYNRIDSRIIEQ CCCCCCCCCHHHHHH | 5.13 | 21890473 | |
778 | Ubiquitination | LWHPYNRIDSRIIEQ CCCCCCCCCHHHHHH | 5.13 | 21890473 | |
780 | Phosphorylation | HPYNRIDSRIIEQIN CCCCCCCHHHHHHHH | 24.02 | 24247654 | |
792 | Phosphorylation | QINEDTGTARAIQRK HHHCCCCCHHHHHCC | 18.31 | - | |
799 | Ubiquitination | TARAIQRKPNPLANS CHHHHHCCCCCCCCC | 32.54 | 21906983 | |
809 | Phosphorylation | PLANSNTSGYSESKK CCCCCCCCCCCCCHH | 39.73 | 28555341 | |
811 | Phosphorylation | ANSNTSGYSESKKDD CCCCCCCCCCCHHHH | 14.72 | 25839225 | |
815 | Ubiquitination | TSGYSESKKDDARAQ CCCCCCCHHHHHHHH | 57.05 | - | |
825 | Ubiquitination | DARAQLMKEDPELAK HHHHHHHHHCHHHHH | 68.50 | - | |
832 | Ubiquitination | KEDPELAKSFIKTLF HHCHHHHHHHHHHHH | 59.53 | - | |
833 | Phosphorylation | EDPELAKSFIKTLFG HCHHHHHHHHHHHHH | 26.96 | 24719451 | |
936 | Phosphorylation | QVKHLAESESLLTSP HHHHHHHCHHHCCCC | 27.21 | 25867546 | |
938 | Phosphorylation | KHLAESESLLTSPPK HHHHHCHHHCCCCCC | 37.65 | 25867546 | |
941 | Phosphorylation | AESESLLTSPPKACT HHCHHHCCCCCCCCC | 44.47 | 30266825 | |
942 | Phosphorylation | ESESLLTSPPKACTN HCHHHCCCCCCCCCC | 38.89 | 29255136 | |
953 | Phosphorylation | ACTNGSGSMGSTTSV CCCCCCCCCCCCCCC | 22.97 | 30576142 | |
977 | Phosphorylation | HAAADLGSPSLQHSR HHHHHCCCCCCCCCC | 20.72 | 30576142 | |
979 | Phosphorylation | AADLGSPSLQHSRDD HHHCCCCCCCCCCCC | 42.21 | 26074081 | |
983 | Phosphorylation | GSPSLQHSRDDSLDL CCCCCCCCCCCCCCC | 25.17 | 26074081 | |
987 | Phosphorylation | LQHSRDDSLDLSPQG CCCCCCCCCCCCCCC | 28.24 | 30266825 | |
989 | Ubiquitination | HSRDDSLDLSPQGRL CCCCCCCCCCCCCCH | 49.40 | 21890473 | |
989 | Ubiquitination | HSRDDSLDLSPQGRL CCCCCCCCCCCCCCH | 49.40 | 21890473 | |
991 | Phosphorylation | RDDSLDLSPQGRLSD CCCCCCCCCCCCHHH | 18.16 | 29255136 | |
997 | Phosphorylation | LSPQGRLSDVLKRKR CCCCCCHHHHHHHCC | 25.06 | 23401153 | |
1001 | Ubiquitination | GRLSDVLKRKRLPKR CCHHHHHHHCCCCCC | 56.58 | 21906983 | |
1015 | Phosphorylation | RGPRRPKYSPPRDDD CCCCCCCCCCCCCCC | 29.14 | 30266825 | |
1016 | Phosphorylation | GPRRPKYSPPRDDDK CCCCCCCCCCCCCCC | 34.26 | 29255136 | |
1018 | Ubiquitination | RRPKYSPPRDDDKVD CCCCCCCCCCCCCCC | 46.52 | 21890473 | |
1018 | Ubiquitination | RRPKYSPPRDDDKVD CCCCCCCCCCCCCCC | 46.52 | 21890473 | |
1029 | Ubiquitination | DKVDNQAKSPTTTQS CCCCCCCCCCCCCCC | 47.40 | - | |
1030 | Phosphorylation | KVDNQAKSPTTTQSP CCCCCCCCCCCCCCC | 30.41 | 23401153 | |
1032 | Phosphorylation | DNQAKSPTTTQSPKS CCCCCCCCCCCCCCH | 49.95 | 23927012 | |
1033 | Phosphorylation | NQAKSPTTTQSPKSS CCCCCCCCCCCCCHH | 26.65 | 23927012 | |
1034 | Phosphorylation | QAKSPTTTQSPKSSF CCCCCCCCCCCCHHH | 29.54 | 23927012 | |
1036 | Phosphorylation | KSPTTTQSPKSSFLA CCCCCCCCCCHHHHH | 32.00 | 23927012 | |
1038 | Ubiquitination | PTTTQSPKSSFLASL CCCCCCCCHHHHHHC | 65.07 | 21906983 | |
1038 | Ubiquitination | PTTTQSPKSSFLASL CCCCCCCCHHHHHHC | 65.07 | 21890473 | |
1039 | Phosphorylation | TTTQSPKSSFLASLN CCCCCCCHHHHHHCC | 29.70 | 26074081 | |
1040 | Phosphorylation | TTQSPKSSFLASLNP CCCCCCHHHHHHCCC | 30.33 | 26074081 | |
1044 | Phosphorylation | PKSSFLASLNPKTWG CCHHHHHHCCCCCCC | 30.72 | 25159151 | |
1048 | Ubiquitination | FLASLNPKTWGRLST HHHHCCCCCCCCCCC | 56.70 | 21906983 | |
1048 | Ubiquitination | FLASLNPKTWGRLST HHHHCCCCCCCCCCC | 56.70 | 21890473 | |
1049 | Phosphorylation | LASLNPKTWGRLSTQ HHHCCCCCCCCCCCC | 34.11 | 22199227 | |
1054 | Phosphorylation | PKTWGRLSTQSNSNN CCCCCCCCCCCCCCC | 24.04 | 29255136 | |
1055 | Phosphorylation | KTWGRLSTQSNSNNI CCCCCCCCCCCCCCC | 40.38 | 29255136 | |
1057 | Phosphorylation | WGRLSTQSNSNNIEP CCCCCCCCCCCCCCC | 42.17 | 29255136 | |
1059 | Phosphorylation | RLSTQSNSNNIEPAR CCCCCCCCCCCCCCH | 36.18 | 29255136 | |
1067 | Phosphorylation | NNIEPARTAGGSGLA CCCCCCHHCCCCHHH | 31.59 | - | |
1078 | Phosphorylation | SGLARAASKDTISNN CHHHHHHCCCCHHCC | 30.04 | 23401153 | |
1079 | Ubiquitination | GLARAASKDTISNNR HHHHHHCCCCHHCCH | 54.91 | - | |
1081 | Phosphorylation | ARAASKDTISNNREK HHHHCCCCHHCCHHH | 30.00 | 27794612 | |
1083 | Phosphorylation | AASKDTISNNREKIK HHCCCCHHCCHHHHH | 30.09 | 26270265 | |
1086 | Ubiquitination | KDTISNNREKIKGWI CCCHHCCHHHHHHHH | 51.33 | 21890473 | |
1096 | Ubiquitination | IKGWIKEQAHKFVER HHHHHHHHHHHHHHH | 43.71 | 21890473 | |
1104 | Phosphorylation | AHKFVERYFSSENMD HHHHHHHHHCCCCCC | 8.36 | 25850435 | |
1106 | Phosphorylation | KFVERYFSSENMDGS HHHHHHHCCCCCCCC | 28.01 | 25850435 | |
1107 | Phosphorylation | FVERYFSSENMDGSN HHHHHHCCCCCCCCC | 24.08 | 25850435 | |
1113 | Phosphorylation | SSENMDGSNPALNVL CCCCCCCCCHHHHHH | 35.06 | 25850435 | |
1146 | Phosphorylation | ECLVEIRSIVSESDV EEEEEEHHEECCCCC | 32.76 | 23898821 | |
1149 | Phosphorylation | VEIRSIVSESDVSSF EEEHHEECCCCCCCE | 29.70 | 23898821 | |
1151 | Phosphorylation | IRSIVSESDVSSFEI EHHEECCCCCCCEEE | 35.49 | 23898821 | |
1154 | Phosphorylation | IVSESDVSSFEIQHS EECCCCCCCEEEECC | 34.01 | 23898821 | |
1155 | Phosphorylation | VSESDVSSFEIQHSG ECCCCCCCEEEECCH | 27.09 | 23898821 | |
1161 | Phosphorylation | SSFEIQHSGFVKQLL CCEEEECCHHHHHHH | 19.97 | 23898821 | |
1170 | Phosphorylation | FVKQLLLYLTSKSEK HHHHHHHHHHCCCHH | 14.11 | 23898821 | |
1172 | Phosphorylation | KQLLLYLTSKSEKDA HHHHHHHHCCCHHHH | 22.13 | 23898821 | |
1173 | Phosphorylation | QLLLYLTSKSEKDAV HHHHHHHCCCHHHHH | 31.43 | 23898821 | |
1174 | Ubiquitination | LLLYLTSKSEKDAVS HHHHHHCCCHHHHHH | 58.35 | - | |
1177 | Ubiquitination | YLTSKSEKDAVSREI HHHCCCHHHHHHHHH | 59.06 | - | |
1221 | Ubiquitination | PLLALVHKMNNCLSQ HHHHHHHHHHHHHHH | 35.52 | - | |
1241 | Phosphorylation | VKVHDFPSGNGTGGS CEEECCCCCCCCCCC | 44.90 | 28450419 | |
1245 | Phosphorylation | DFPSGNGTGGSFSLN CCCCCCCCCCCCCCC | 42.23 | 28450419 | |
1248 | Phosphorylation | SGNGTGGSFSLNRGS CCCCCCCCCCCCCCC | 17.01 | 28450419 | |
1250 | Phosphorylation | NGTGGSFSLNRGSQA CCCCCCCCCCCCCHH | 26.82 | 28450419 | |
1259 | Ubiquitination | NRGSQALKFFNTHQL CCCCHHHHHCCHHHH | 51.42 | 21890473 | |
1259 | Ubiquitination | NRGSQALKFFNTHQL CCCCHHHHHCCHHHH | 51.42 | 21890473 | |
1267 | Acetylation | FFNTHQLKCQLQRHP HCCHHHHHHHHHCCC | 17.23 | 25953088 | |
1267 | Ubiquitination | FFNTHQLKCQLQRHP HCCHHHHHHHHHCCC | 17.23 | - | |
1280 | Acetylation | HPDCANVKQWKGGPV CCCCCCCCCCCCCCC | 50.69 | 19816199 | |
1280 | Ubiquitination | HPDCANVKQWKGGPV CCCCCCCCCCCCCCC | 50.69 | - | |
1283 | Acetylation | CANVKQWKGGPVKID CCCCCCCCCCCCCCC | 52.04 | 19816211 | |
1283 | Ubiquitination | CANVKQWKGGPVKID CCCCCCCCCCCCCCC | 52.04 | - | |
1288 | Acetylation | QWKGGPVKIDPLALV CCCCCCCCCCHHHHH | 44.52 | 23236377 | |
1288 | Ubiquitination | QWKGGPVKIDPLALV CCCCCCCCCCHHHHH | 44.52 | 21890473 | |
1288 | Ubiquitination | QWKGGPVKIDPLALV CCCCCCCCCCHHHHH | 44.52 | 21890473 | |
1307 | Ubiquitination | RYLVVRGYGRVREDD HHHHHCCCCCCCCCC | 7.38 | 21890473 | |
1317 | Phosphorylation | VREDDEDSDDDGSDE CCCCCCCCCCCCCHH | 40.67 | 26503892 | |
1322 | Phosphorylation | EDSDDDGSDEEIDES CCCCCCCCHHHHHHH | 49.17 | 26503892 | |
1329 | Phosphorylation | SDEEIDESLAAQFLN CHHHHHHHHHHHHHH | 21.40 | 28176443 | |
1336 | Ubiquitination | SLAAQFLNSGNVRHR HHHHHHHHCCCHHHE | 49.51 | 21890473 | |
1347 | Phosphorylation | VRHRLQFYIGEHLLP HHHEEEEEECCCCCC | 8.61 | 24043423 | |
1355 | Phosphorylation | IGEHLLPYNMTVYQA ECCCCCCCCCHHHHH | 19.96 | 24043423 | |
1358 | Phosphorylation | HLLPYNMTVYQAVRQ CCCCCCCHHHHHHHH | 16.66 | 24043423 | |
1360 | Phosphorylation | LPYNMTVYQAVRQFS CCCCCHHHHHHHHHC | 5.00 | 24043423 | |
1367 | Phosphorylation | YQAVRQFSIQAEDER HHHHHHHCCCCCCCC | 12.88 | 23927012 | |
1374 | Methylation | SIQAEDERESTDDES CCCCCCCCCCCCCCC | 56.33 | 115918973 | |
1376 | Phosphorylation | QAEDERESTDDESNP CCCCCCCCCCCCCCC | 43.27 | 26503892 | |
1377 | Phosphorylation | AEDERESTDDESNPL CCCCCCCCCCCCCCC | 42.59 | 26503892 | |
1381 | Phosphorylation | RESTDDESNPLGRAG CCCCCCCCCCCCCCC | 51.22 | 30266825 | |
1399 | Ubiquitination | KTHTIWYKPVREDEE ECEEEEEECCCCCHH | 23.26 | - | |
1421 | Phosphorylation | GKRGRAQTAPTKTSP CCCCCCCCCCCCCCC | 33.35 | 23927012 | |
1424 | Phosphorylation | GRAQTAPTKTSPRNA CCCCCCCCCCCCCCH | 44.48 | 30266825 | |
1425 | Acetylation | RAQTAPTKTSPRNAK CCCCCCCCCCCCCHH | 46.04 | - | |
1425 | Ubiquitination | RAQTAPTKTSPRNAK CCCCCCCCCCCCCHH | 46.04 | - | |
1426 | Phosphorylation | AQTAPTKTSPRNAKK CCCCCCCCCCCCHHC | 46.58 | 23401153 | |
1427 | Phosphorylation | QTAPTKTSPRNAKKH CCCCCCCCCCCHHCC | 24.34 | 26846344 | |
1500 | Phosphorylation | MCKEIIPTSEFINSK CCCHHCCHHHHHHHH | 30.40 | 21406692 | |
1501 | Phosphorylation | CKEIIPTSEFINSKL CCHHCCHHHHHHHHH | 25.75 | 21406692 | |
1506 | Phosphorylation | PTSEFINSKLTAKAN CHHHHHHHHHHHHHH | 24.99 | 21406692 | |
1507 | Ubiquitination | TSEFINSKLTAKANR HHHHHHHHHHHHHHH | 45.42 | - | |
1524 | Phosphorylation | QDPLVIMTGNIPTWL CCCEEEEECCCHHHH | 18.89 | 20068231 | |
1529 | Phosphorylation | IMTGNIPTWLTELGK EEECCCHHHHHHHHC | 29.34 | 20068231 | |
1532 | Phosphorylation | GNIPTWLTELGKTCP CCCHHHHHHHHCCCC | 22.26 | 20068231 | |
1552 | Phosphorylation | DTRQMLFYVTAFDRD CHHHHEEEEEECCHH | 7.91 | 23663014 | |
1554 | Phosphorylation | RQMLFYVTAFDRDRA HHHEEEEEECCHHHH | 15.38 | 23663014 | |
1568 | Phosphorylation | AMQRLLDTNPEINQS HHHHHHHCCCCCCCC | 53.28 | 20873877 | |
1575 | Phosphorylation | TNPEINQSDSQDSRV CCCCCCCCCCCCCCH | 34.44 | 29255136 | |
1577 | Phosphorylation | PEINQSDSQDSRVAP CCCCCCCCCCCCHHH | 40.93 | 17525332 | |
1580 | Phosphorylation | NQSDSQDSRVAPRLD CCCCCCCCCHHHHHC | 22.48 | 29255136 | |
1592 | Phosphorylation | RLDRKKRTVNREELL HHCHHCCCCCHHHHH | 30.89 | 22817900 | |
1600 | Ubiquitination | VNREELLKQAESVMQ CCHHHHHHHHHHHHH | 61.15 | 21906983 | |
1661 | Ubiquitination | EVTLSNPKGSQEGTK EEECCCCCCCHHHHH | 75.37 | 21906983 | |
1663 | Phosphorylation | TLSNPKGSQEGTKYI ECCCCCCCHHHHHHH | 31.05 | - | |
1668 | Ubiquitination | KGSQEGTKYIQNLQG CCCHHHHHHHHHHHH | 51.73 | - | |
1686 | Ubiquitination | LPFGRTAKPAHIAKV CCCCCCCCCHHHHHH | 41.97 | - | |
1692 | Ubiquitination | AKPAHIAKVKMKFRF CCCHHHHHHHHHHHH | 41.61 | - | |
1702 | Ubiquitination | MKFRFLGKLMAKAIM HHHHHHHHHHHHHHH | 36.92 | - | |
1706 | Ubiquitination | FLGKLMAKAIMDFRL HHHHHHHHHHHHHCC | 25.20 | - | |
1724 | Ubiquitination | PLGLPFYKWMLRQET CCCCCHHHHHHHCCC | 26.89 | - | |
1766 | Ubiquitination | KKRLEQDKSQTKESL HHHHHHCHHHHHHHH | 44.13 | - | |
1795 | Phosphorylation | EDLGLDFTLPGFPNI HHCCCCCCCCCCCCE | 31.54 | 26074081 | |
1809 | Ubiquitination | IELKKGGKDIPVTIH EEECCCCEECCEEEC | 62.24 | - | |
1814 | Phosphorylation | GGKDIPVTIHNLEEY CCEECCEEECCHHHH | 15.91 | 26074081 | |
1840 | Phosphorylation | GVSRQFDSFRDGFES CHHHHCHHHHCCCHH | 24.38 | 22468782 | |
1847 | Phosphorylation | SFRDGFESVFPLSHL HHHCCCHHCCCHHHH | 27.14 | 22468782 | |
1852 | Phosphorylation | FESVFPLSHLQYFYP CHHCCCHHHHHHHCH | 23.53 | 22468782 | |
1856 | Phosphorylation | FPLSHLQYFYPEELD CCHHHHHHHCHHHHH | 16.08 | 22468782 | |
1877 | Ubiquitination | KADTWDAKTLMECCR CCCCCCHHHHHHHCC | 39.45 | - | |
1937 | Phosphorylation | RSLNPPLTIVRKTFE CCCCCCEEEEEHHHC | 24.17 | - | |
1941 | Ubiquitination | PPLTIVRKTFESTEN CCEEEEEHHHCCCCC | 46.82 | - | |
1942 | Phosphorylation | PLTIVRKTFESTENP CEEEEEHHHCCCCCH | 23.28 | - | |
1955 | Phosphorylation | NPDDFLPSVMTCVNY CHHCHHHHHHHHHHH | 27.03 | - | |
1977 | Ubiquitination | SIEIMREKLLIAARE HHHHHHHHHHHHHHC | 37.92 | - | |
1988 | Phosphorylation | AAREGQQSFHLS--- HHHCCCCCCCCC--- | 13.52 | 27499020 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
1078 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRIPC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRIPC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ULA1_HUMAN | NAE1 | physical | 18627766 | |
CDN2A_HUMAN | CDKN2A | physical | 20208519 | |
ARF_HUMAN | CDKN2A | physical | 20208519 | |
MYC_HUMAN | MYC | physical | 20208519 | |
TRADD_HUMAN | TRADD | physical | 22561347 | |
NMI_HUMAN | NMI | physical | 23034180 | |
CDN2A_HUMAN | CDKN2A | physical | 23034180 | |
ARF_HUMAN | CDKN2A | physical | 23034180 | |
UB2D1_HUMAN | UBE2D1 | physical | 18627766 | |
UB2D1_HUMAN | UBE2D1 | physical | 9575161 | |
UB2L3_HUMAN | UBE2L3 | physical | 9575161 | |
SOX6_HUMAN | SOX6 | physical | 23663701 | |
UB2D1_HUMAN | UBE2D1 | physical | 23663701 | |
GNL3_HUMAN | GNL3 | physical | 24769896 | |
UB2D1_HUMAN | UBE2D1 | physical | 19028681 | |
UBC_HUMAN | UBC | physical | 19028681 | |
PTF1A_HUMAN | PTF1A | physical | 25355311 | |
UBP7_HUMAN | USP7 | physical | 27800609 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-991; SER-1317AND SER-1322, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310; SER-312; SER-991;SER-997; SER-1317 AND SER-1322, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1577, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-88 AND SER-1427,AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-991, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND THR-1592, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-507, AND MASSSPECTROMETRY. |